Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Capital Expenditures (2020 - 2026)

Aura Biosciences filings provide 7 years of Capital Expenditures readings, the most recent being $20000.0 for Q1 2026.

  • Quarterly Capital Expenditures fell 89.3% to $20000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $280000.0 through Mar 2026, up 180.0% year-over-year, with the annual reading at $447000.0 for FY2025, 1177.14% up from the prior year.
  • Capital Expenditures hit $20000.0 in Q1 2026 for Aura Biosciences, down from $176000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $644000.0 in Q4 2023 and bottomed at -$919000.0 in Q4 2024.
  • Average Capital Expenditures over 5 years is $81823.5, with a median of $122000.0 recorded in 2024.
  • Peak annual rise in Capital Expenditures hit 743.66% in 2022, while the deepest fall reached 313.58% in 2022.
  • Aura Biosciences' Capital Expenditures stood at -$556000.0 in 2022, then surged by 215.83% to $644000.0 in 2023, then tumbled by 242.7% to -$919000.0 in 2024, then skyrocketed by 119.15% to $176000.0 in 2025, then plummeted by 88.64% to $20000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Capital Expenditures are $20000.0 (Q1 2026), $176000.0 (Q4 2025), and $45000.0 (Q3 2025).